PWR
72
-2
BAC
57
3
A
40
-3
LB
49
-33
ICE
62
3
BMY
64
21
KR
50
-2
TXN
55
-4
INTC
48
5
AVGO
37
-7
AFL
49
3
SLB
57
4
DGX
48
-2
NEM
38
-4
MRK
27
-3
AAP
39
7
CRM
75
8
AZO
58
5
WYNN
30
2
PLD
46
-4
PWR
72
-2
BAC
57
3
A
40
-3
LB
49
-33
ICE
62
3
BMY
64
21
KR
50
-2
TXN
55
-4
INTC
48
5
AVGO
37
-7
AFL
49
3
SLB
57
4
DGX
48
-2
NEM
38
-4
MRK
27
-3
AAP
39
7
CRM
75
8
AZO
58
5
WYNN
30
2
PLD
46
-4
Financhill
Back

Alaunos Therapeutics Quote, Financials, Valuation and Earnings

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!
Sell
20

TCRT
Alaunos Therapeutics

Last Price:
2.32
Seasonality Move:
11.94%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.

Alaunos Therapeutics Price Quote

$2.32
+0.22 (+10.48%)
(Updated: November 12, 2024 at 5:55 PM ET)

Alaunos Therapeutics Key Stats

Sell
20
Alaunos Therapeutics (TCRT) is a Sell
Day range:
$1.95 - $2.15
52-week range:
$1.95 - $32.85
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.89%
Volume:
41.3K
Avg. volume:
13.4K
1-year change:
-85.25%
Market cap:
$3.4M
Revenue:
$5K
EPS:
$-12.71

How Much Does Alaunos Therapeutics Make?

Data Unavailable

Is Alaunos Therapeutics Growing As A Company?

  • What Is Alaunos Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0%
  • What Is Alaunos Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Alaunos Therapeutics Stock Price Performance

What Is Alaunos Therapeutics 52-Week High & Low?

Alaunos Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Alaunos Therapeutics?

Is Alaunos Therapeutics Cash Flow Positive?

  • What Is TCRT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$17.4M
  • What Is Alaunos Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $0
  • What Is Alaunos Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $1.5M

Alaunos Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    TCRT return on invested capital is -189.69%
  • What Is Alaunos Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -144.17%
  • What Is TCRT Return On Equity?
    ROE is a measure of profitability and is -189.69%

Alaunos Therapeutics Earnings Date & Stock Price

Alaunos Therapeutics Competitors

Alaunos Therapeutics Dividend Yield

Alaunos Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -279.87%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 205.50
Upside from Last Price: 9685.71%

Major Shareholders

  • How many TCRT shares are owned by institutional investors?
    737.1K TCRT shares are owned by institutional investors
  • How many TCRT shares are owned by insiders?
    0 TCRT shares are owned by insiders